My cancer saved my mom’s life, even though it almost killed her. That’s how she feels, anyway. She does, however, have a valid point.
She was first diagnosed in 2002, at 52 years of age. No one talked about genetic testing then. No one talked about red flags. Because she was diagnosed after 50, it was just thought to be a sporadic cancer, especially since there was no family history; she was the first.
There are a few factors that could possibly point to hereditary cancer, they are: multiple family members with cancer; early age of onset; multiple cancers in the same individual; occurrence of rare cancers; and Ashkenazi (Eastern European) Jewish heritage. My mom and dad are both of Ashkenazi descent.
No one told any of these factors. No one told us that there was a genetic test available. When I told my OB-GYN that my mom had been diagnosed with breast cancer, she said I didn’t need to worry about getting mammograms until age 40.
When I was diagnosed, I was 37. That, in and of itself, was a red flag. Add to that the fact that I had the family history, and the Ashkenazi heritage – no one hesitated to discuss genetic counseling and testing with me. Why must they wait until someone already HAS cancer!
Of course I chose to be tested and the result was positive for a BRCA2 mutation – the “Jewish Panel” they call it. I’ll get into what this means shortly, so keep reading.
Genetic testing isn’t cheap; it costs around $3,000-$5,000. Most insurance companies will not pay for it unless there are those significant red flags. Even though my mom had one red flag, given her age at diagnosis and lack of family history, her insurance company would most likely not have paid for a genetic test.
My mom went to her Oncologist with my results and she was scheduled immediately for genetic counseling and testing. Once I was diagnosed, however, her insurance company agreed to pay for the test without a problem. Her results were positive for a BRCA2 mutation – surprise! Also, she was scheduled for a breast MRI to have a baseline. That MRI showed a 3mm mass that was of slight concern, but the doctors told her they’d recheck it in a few months.
We both chose risk-reducing surgery. We both decided to undergo a bilateral mastectomy with reconstruction and a bilateral salpingo oopherectomy, or removal of ovaries and fallopian tubes. The removal of the ovaries and tubes was a no-brainer for both of us. Ovarian cancer is known as the “silent killer” because it often goes undetected until it is too late.
My mom had her oopherectomy surgery right away as I started chemotherapy. I then had my bilateral mastectomy and reconstruction, while she waited so she could help take care of me. Once my recovery was manageable, she was ready to have hers.
So about six months after that baseline MRI, she was ready for surgery and was sent for a pre-op MRI. The mass had grown to 9mm. The doctor said that nothing good grows from 3mm to 9mm in only 6 months. We knew it was bad news, but were also relieved that at least she was already scheduled for the surgery and that the tumor will be coming out. By the time she had the surgery, the tumor had grown to 1.2 cm. It was malignant and was a different kind of cancer than what she had had the first time. She’s currently going through chemotherapy.
Three weeks ago, I had my ovaries and tubes removed. I am in remission. My mom will be a two-time survivor.
The moral here is that if my mom had received the genetic test when she was first diagnosed with breast cancer in 2002, this may have turned out very differently. Had she had the test, it would have showed the mutation, then my sister and I would have had the test and I would have known way before I ever got cancer that I was at risk (by the way, my sister was tested and does not have the mutation). My mom and I would then have discussed risk-reducing surgery, and if we chose to do that, it could have prevented me from ever getting cancer and my mom from getting cancer a second time. However, that’s not the way it happened and it ultimately took my getting cancer to trigger the genetic testing. Without that, my mom may not have found that new tumor until it was too late. Therefore, even though it nearly killed my mom to find out that her daughter had cancer, it saved her life.
My mom’s doctor never even talked to her about genetic testing. Doctors need to be more aware and open to all possibilities with the care of their patients. And insurance companies need to be more willing to pay for testing when there’s the potential to save hundreds of thousands of dollars for cancer treatment.
Showing posts with label genetics testing. Show all posts
Showing posts with label genetics testing. Show all posts
Saturday, August 7, 2010
late July, 2008: genetic test results & statistics
Two weeks after the lumpectomy surgery, I went in to see the genetic counselor for my test results. She told me that my blood test came back positive for carrying the BRCA2 gene mutation. I knew it was a possibility, but I didn’t think it would be so. I thought my cancer was just an unlucky fluke.
My first thought went to my babies – this means that they each have a 50/50 chance of also having it; what a horrible feeling to know that I did this to them. Even though I had no clue I had it, I feel so guilty. At least they’ll grow up knowing and being vigilant about it so they can remain healthy and hopefully they’ll never ever get this. My poor babies. They don’t even have a clue how serious what I have is, but I guess it’s better that way. I’ll make it though this hurdle, too.
When I saw the surgeon next she highly recommended I have a bilateral mastectomy and oopherectomy to reduce my risk or recurrence or of getting a new cancer.
Here are some facts about cancer and BRCA2 gene mutations:
For most people who get cancer, the mutations in the genes happen at random and do not run in families. This is referred to as sporadic cancer. However, in some families, mutations that increase the risk for cancer can be passed down from one generation to the next. These types of cancers are referred to as hereditary cancers. Approximately 5% to 10% of breast and ovarian cancers are associated with inherited mutations in cancer susceptibility genes.
BRCA2 mutations lead to markedly increased lifetime risks for breast and ovarian cancer. Although the exact level of risk can vary among and within families, the current estimates of cancer risk for individuals who are positive for mutations in BRCA2 are:
BRCA mutation carriers have the following management options available:
My first thought went to my babies – this means that they each have a 50/50 chance of also having it; what a horrible feeling to know that I did this to them. Even though I had no clue I had it, I feel so guilty. At least they’ll grow up knowing and being vigilant about it so they can remain healthy and hopefully they’ll never ever get this. My poor babies. They don’t even have a clue how serious what I have is, but I guess it’s better that way. I’ll make it though this hurdle, too.
When I saw the surgeon next she highly recommended I have a bilateral mastectomy and oopherectomy to reduce my risk or recurrence or of getting a new cancer.
Here are some facts about cancer and BRCA2 gene mutations:
For most people who get cancer, the mutations in the genes happen at random and do not run in families. This is referred to as sporadic cancer. However, in some families, mutations that increase the risk for cancer can be passed down from one generation to the next. These types of cancers are referred to as hereditary cancers. Approximately 5% to 10% of breast and ovarian cancers are associated with inherited mutations in cancer susceptibility genes.
BRCA2 mutations lead to markedly increased lifetime risks for breast and ovarian cancer. Although the exact level of risk can vary among and within families, the current estimates of cancer risk for individuals who are positive for mutations in BRCA2 are:
- Risk of breast cancer (in women) up to 34% by age 50, up to 85% by age 80
- Risk of breast cancer (in men) up to 7% by age 80
- Risk of second breast cancer in women up to 50% by age 70, up to 12% risk of primary breast cancer within 5 years of the first
- Risk of ovarian cancer up to 2% by age 50, up to 27% by age 80
- Risk of other cancers (prostate, melanoma, pancreatic) may also be increased above the general population
BRCA mutation carriers have the following management options available:
- Healthy lifestyle – a high fiber, low fat diet and regular exercise, alcohol only in moderation, no tobacco products. It’s not yet known to what effect, if any, lifestyle factors may have on hereditary breast and ovarian cancer susceptibility. However, they may benefit many aspects of a person’s overall health.
- Surveillance & screening – for breast cancer in women, mammograms, clinical breast exams and self-breast exams on a regular basis.
- For ovarian cancer – pelvic exams every 6 to 12 months, as well as transvaginal ultrasound, and annual CA-125 blood test. Currently, there is no evidence to prove that these tests are effective in reducing ovarian cancer mortality.
- For pancreatic cancer – reports indicate increased risk in families with BRCA2 mutations; however, there currently are no proven screening methods for pancreatic cancer.
- Risk reducing surgery (for breast cancer) – prophylactic mastectomy. Studies of the effect of risk reducing mastectomy in women with BRCA1 & 2 mutations report that the surgery decreases the risk of breast cancer by 90%.
- Risk reducing surgery (for ovarian cancer) – prophylactic salpingo-oopherectomy (removal of the ovaries and fallopian tubes). Studies of women with BRCA 1 & 2 mutations who underwent this procedure report a risk reduction in the range of 95% or more. This procedure performed on women before menopause would also reduce the risk of breast cancer.
- Chemoprevention (for breast cancer) – several chemotherapeutic agents such as Tamoxifen and Raloxifen may have a role in reducing risk of breast cancer in high-risk families.
- Chemoprevention (for ovarian cancer) – birth control pills reduce the risk in the general population. One study reports that this effect may also apply to carriers of BRCA 1 & 2 mutations, in whom the risk may be reduced by as much as 50%.
July 1, 2008: visit with a genetics counselor
Met with the genetics counselor. Was referred due to cancer diagnosis at age 37, family history [mom was diagnosed with breast cancer in 2002] and Ashkenazi heritage – all red flags apparently.
She told me that there’s a 12% probability of me having a hereditary cancer gene, based on family history.
I went to the lab and had my blood drawn for the test; they said it would take 2 – 5 weeks for the result.
Meanwhile, my lumpectomy is scheduled for July 7th, six days from now.
She told me that there’s a 12% probability of me having a hereditary cancer gene, based on family history.
I went to the lab and had my blood drawn for the test; they said it would take 2 – 5 weeks for the result.
Meanwhile, my lumpectomy is scheduled for July 7th, six days from now.
Labels:
breast cancer,
breast cancer diagnosis,
breast cancer survivor,
breast lump,
breast tumor,
cancer,
cancer gene,
cancer treatment,
genetics test for cancer,
genetics testing,
my breast cancer
Subscribe to:
Posts (Atom)